Candoxatrilat en es it fr

Candoxatrilat Brand names, Candoxatrilat Analogs

Candoxatrilat Brand Names Mixture

  • No information avaliable

Candoxatrilat Chemical_Formula

C29H41NO7

Candoxatrilat RX_link

No information avaliable

Candoxatrilat fda sheet

Candoxatrilat msds (material safety sheet)

Candoxatrilat Synthesis Reference

No information avaliable

Candoxatrilat Molecular Weight

515.638 g/mol

Candoxatrilat Melting Point

No information avaliable

Candoxatrilat H2O Solubility

No information avaliable

Candoxatrilat State

Solid

Candoxatrilat LogP

4.874

Candoxatrilat Dosage Forms

No information avaliable

Candoxatrilat Indication

For treatment of hypertension, improve exercise capacity in patients with CHF receiving angiotensin converting enzyme inhibition.

Candoxatrilat Pharmacology

Candoxatril is the orally-active prodrug of candoxatrilat (UK-73967), the active enantiomer of candoxatrilat (UK-69578), a potent neutral endopeptidase (NEP) inhibitor used in the treatment of chronic heart failure in man.

Candoxatrilat Absorption

No information avaliable

Candoxatrilat side effects and Toxicity

No information avaliable

Candoxatrilat Patient Information

No information avaliable

Candoxatrilat Organisms Affected

Humans and other mammals